Thomas Cerny
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 15
- Lung Cancer Research Studies 3
- Pancreatic and Hepatic Oncology Research 3
-
- vaccines and immunoinformatics approaches 3
- Co-authors
- Florian Strasser (8 shared papers)N. Thatcher (4 shared papers)P S Hasleton (3 shared papers)Ulrich Güller (9 shared papers)Jim Heighway (2 shared papers)Markus Joerger (9 shared papers)Thomas Ruhstaller (2 shared papers)René Warschkow (7 shared papers)
- Journals
- British Journal of Cancer (6 papers)Journal of Clinical Oncology (5 papers)Lung Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Pancreas (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Thomas Cerny
53 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 119
- Oncology 680
- Pathology and Forensic Medicine 240
- Cancer Research 193
- Pharmacology 176
- Immunology 223
Countries citing papers authored by Thomas Cerny
This map shows the geographic impact of Thomas Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cerny more than expected).
Fields of papers citing papers by Thomas Cerny
This network shows the impact of papers produced by Thomas Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cerny. The network helps show where Thomas Cerny may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Cerny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 297 | |
| 2 | 1996 | 191 | |
| 3 | Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. | 2000 | 130 |
| 4 | 2011 | 128 | |
| 5 | 1986 | 128 | |
| 6 | 2006 | 95 | |
| 7 | 2014 | 94 | |
| 8 | 2007 | 87 | |
| 9 | 1986 | 81 | |
| 10 | 2017 | 79 | |
| 11 | 2010 | 71 | |
| 12 | 2015 | 66 | |
| 13 | 2013 | 64 | |
| 14 | 2013 | 60 | |
| 15 | 2002 | 52 | |
| 16 | 2015 | 47 | |
| 17 | 1992 | 45 | |
| 18 | 2017 | 40 | |
| 19 | 2009 | 39 | |
| 20 | 2017 | 37 |
About Thomas Cerny
Thomas Cerny is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 53 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Research Studies (3 papers), T-cell and B-cell Immunology (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Palliative Care and End-of-Life Issues (3 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Oncology (680 citations), Pathology and Forensic Medicine (240 citations), Cancer Research (193 citations), Pharmacology (176 citations) and Immunology (223 citations). Thomas Cerny has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Florian Strasser, N. Thatcher, P S Hasleton, Ulrich Güller, Jim Heighway, Markus Joerger, Thomas Ruhstaller, René Warschkow, Mathias Worni and Bruno M. Schmied. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Lung Cancer, Cancer Chemotherapy and Pharmacology and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.